<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04658225</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE: 69912817.0.0000.5626.</org_study_id>
    <nct_id>NCT04658225</nct_id>
  </id_info>
  <brief_title>Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults</brief_title>
  <official_title>Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal Fluminense</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal Fluminense</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study will evaluate the effectiveness of 0.12% chlorhexidine solution as an&#xD;
      anti-inflammatory agent and reducing the presence of biofilm in young adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty patients with gingivitis ages 18 to 30 year with a probing depth of at most 3 mm and&#xD;
      at least 20 teeth will be selected and evaluate at baseline and after 4 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Thirty patients with gingivitis ages18 to 30 year with a probing depth of at most 3 mm and at least 20 teeth will select and evaluate at baseline and after 4 weeks. The periodontal clinical parameters will verify: plaque index (PI), gingival index (GI) and Simplified Oral Hygiene Index (OHIS). After evaluation of the clinical parameters, the patients will randomly allocated into two groups of 15 individuals to rinse with antimicrobials twice a day for a period of four weeks. Group A, received 0.12% chlorhexidine antimicrobian in a vial previously identified as solution 1 and group B, received saline solution identified as solution 2.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Participant will receiver mouthwash solution with labeled number, they will not know which solution will inside.&#xD;
Care provider - The research that will collect clinical parameter wil be different for researcher that will do the treatment.&#xD;
Investigator will not have contact with treatment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Plaque Index</measure>
    <time_frame>30 days</time_frame>
    <description>Check the biofilm as Ainano &amp; Bay 1975 index, Higher levels means worse.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gingival Index</measure>
    <time_frame>30 days</time_frame>
    <description>Check the biofilm as Ainano &amp; Bay 1975 index, Higher levels means worse.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Age Problem</condition>
  <arm_group>
    <arm_group_label>Solution 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.12% chlorhexidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Solution 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>0.12% chlorhexidine</intervention_name>
    <description>the patients were randomly allocated into two groups of 15 individuals to rinse with antimicrobials twice a day for a period of four weeks. Group A, received 0.12% chlorhexidine antimicrobian in a vial previously identified as solution 1 and group B, received saline solution identified as solution 2.</description>
    <arm_group_label>Solution 1</arm_group_label>
    <arm_group_label>Solution 2</arm_group_label>
    <other_name>Saline Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Presence of gingivitis&#xD;
&#xD;
          -  Probing depth (PD) with maximum 3 mm&#xD;
&#xD;
          -  Minimum of 20 teeth&#xD;
&#xD;
          -  Age between 18 and 30 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with periodontal disease (PD â‰¥ 4mm with clinical attachment loss)&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Osteoporosis&#xD;
&#xD;
          -  Pregnant or lactating females&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Users of immune suppressive medication&#xD;
&#xD;
          -  Phenytoin or cyclosporine&#xD;
&#xD;
          -  Calcium channel blockers&#xD;
&#xD;
          -  Antibiotics&#xD;
&#xD;
          -  Nonsteroidal anti-inflammatory drugs&#xD;
&#xD;
          -  HIV+ or AIDS&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidade Federal Fluminense</name>
      <address>
        <city>Nova Friburgo</city>
        <state>Rio De Janeiro</state>
        <zip>28625650</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 1, 2020</study_first_submitted>
  <study_first_submitted_qc>December 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>December 9, 2020</last_update_submitted>
  <last_update_submitted_qc>December 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal Fluminense</investigator_affiliation>
    <investigator_full_name>Gabriela Alessandra da Cruz Galhardo Camargo</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Gingivitis</keyword>
  <keyword>Periodontal treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

